Top compounds associated with response to CTSH


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA PI-103 GDSC1000 pan-cancer AAC -0.096 0.004
mRNA GW-2580 GDSC1000 pan-cancer AAC -0.11 0.004
mRNA Genentech Cpd 10 GDSC1000 pan-cancer AAC -0.097 0.004
mRNA WH-4-023 GDSC1000 pan-cancer AAC 0.15 0.004
mRNA ibrutinib CTRPv2 pan-cancer AAC 0.13 0.004
mRNA T0901317 GDSC1000 pan-cancer AAC -0.1 0.004
mRNA GSK1070916 GDSC1000 pan-cancer AAC -0.096 0.005
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.005
mRNA neopeltolide CTRPv2 pan-cancer AAC -0.2 0.005
Download CSV